Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rovi Pharmaceuticals Laboratories

Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.

Now part of Laboratorios Farmaceuticos Rovi, S.A. ROVI BME

Pharmaceutical company focused on injectable drugs and heparin products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1 Completed 3

New shot could replace daily pill for advanced breast cancer

Disease control Not yet recruiting

This phase 3 trial compares an injectable form of letrozole (given every 3 months) to the standard daily oral pill, both combined with ribociclib, in 300 postmenopausal women with advanced HR-positive, HER2-negative breast cancer. The goal is to see if the injection works as well…

Phase: PHASE3 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC